Accelerated Approval and Considerations for Determining Whether a Confirmatory Trial is Underway
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 7, 2025
January 6, 2025
ae83d008-58ac-4e99-bb05-ca1492236392
Related Documents
Drug Master Files Guidance for Industry
Guidance DocumentNovember 15, 2019Center for Drug Evaluation and Research
Accelerated Approval – Expedited Program for Serious Conditions
Guidance DocumentDecember 5, 2024Center for Drug Evaluation and Research
Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics
Guidance DocumentMarch 24, 2023Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox